Anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SW480 cells
WANG Guo-yu1;XIA Wei1;ZHANG Yu-na1;LI Yan2;ZHU Xue-ping1;WANG Ying3;NI Jing1 1.Department of Nuclear Medicine;Shanghai Putuo District People’s Hospital;Shanghai 200060;P.R.China 2.Central Laboratory;Shanghai First Maternity and Infant Hospital;Tongji University;Shanghai 200040;P.R.China 3.Department of Nuclear Medicine;Shanghai Xuhui District Central Hospital;Shanghai 200031;P.R.China
..............page:1676-1680
..............page:1681-1684
..............page:1703-1707
..............page:1708-1712
..............page:1696-1699
..............page:1672-1675
Advances in vasculogenic mimicry
JI Hai-ning;XIN Yan;XIAO Yu-ping Fourth Lab of Cancer Institute;Department of Tumor Pathology of General Surgery Institute;First Affiliated Hospital of China Medical University;Shenyang 110001;P.R.China
..............page:1736-1740
Efficacy and safety of pemetrexed in advanced primary adenocarcinoma of lung
HAN Jin-di1;FANG Jian1;NIE Jun1;DAI Ling1;WANG Yi-shang2;HU Wei-heng1;CHENG Xiao-ling1;TIAN Guang-ming1;HAN Sen1;WANG Gang3;GAO Wen-bin3;LIU Xu-yi1 1.Oncology Outpatieat Treatment Area;Key Laboratory of Carcinogenesis and Translational Research;Peking University Cancer Hospital & Institute;Beijing 100142;P.R.China 2.Department of Oncology;Chinese PLA General Hospital;Beijing 100853;P.R.China 3.Department of Oncology;Affiliated Zhongshan Hospital of Dalian University;Dalian 116001;P.R.China
..............page:1722-1724
..............page:1725-1727
..............page:1720-1721
..............page:1741-1742
..............page:1732-1735,1740
..............page:1688-1690,1707
..............page:1700-1702
..............page:1685-1687
..............page:1661-1664,1668
..............page:1665-1668
..............page:1713-1716
..............page:1691-1695
..............page:1669-1671
..............page:1730-1731
..............page:1717-1719
..............page:1728-1729